Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus

Cancer cell lines responded differentially to type I interferon treatment in models of oncolytic therapy using vesicular stomatitis virus (VSV). Two opposite cases were considered in this study, glioblastoma DBTRG-05MG and osteosarcoma HOS cell lines exhibiting resistance and sensitivity to VSV afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikitina, Anastasia S., Lipatova, Anastasia V., Goncharov, Anton O., Kliuchnikova, Anna A., Pyatnitskiy, Mikhail A., Kuznetsova, Ksenia G., Hamad, Azzam, Vorobyev, Pavel O., Alekseeva, Olga N., Mahmoud, Marah, Shakiba, Yasmin, Anufrieva, Ksenia S., Arapidi, Georgy P., Ivanov, Mark V., Tarasova, Irina A., Gorshkov, Mikhail V., Chumakov, Peter M., Moshkovskii, Sergei A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102229/
https://www.ncbi.nlm.nih.gov/pubmed/35563635
http://dx.doi.org/10.3390/ijms23095244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102229/
https://www.ncbi.nlm.nih.gov/pubmed/35563635
http://dx.doi.org/10.3390/ijms23095244

Ejemplares similares